Germitec
France
- Bordeaux, Nouvelle-Aquitaine
- 14/02/2025
- Unknown
- $30,000,000
Germitec’s mission is to improve the standard of care by reducing cross-contamination risk and offering healthcare professionals with an automated solution that is fast, simple, safe, and environmentally friendly.
Our products uses patented Yuvee® UV-C technology to provide High-Level Disinfection (HLD) for endocavitary and external ultrasound probes.
- Industry Hospital & Health Care
- Website https://www.germitec.com/en-us
- LinkedIn https://www.linkedin.com/company/germitec-s-a/
Related People
Vincent GardèsFounder
France -
Bordeaux, Nouvelle-Aquitaine
Provide Leadership in the MedTech Industry with a special insight on European &US markets.
Successful Sales, Marketing, People and Financial leadership experience (IPO, secondary offers, M&A).
Strong value creation exits as CEO & Chairman.
International experience and culture.
Turn around of organizations (small & mid size), company integration & financing, define and execute sound strategies. Strong business acumen.
Keep learning, have fun !
Cara | $8,000,000 | (Apr 2, 2026)
Rowan(US) | $3,300,000 | (Apr 2, 2026)
Earlyasset | $2,000,000 | (Apr 2, 2026)
Sona(UK) | $45,000,000 | (Apr 2, 2026)
Variance | $21,500,000 | (Apr 2, 2026)
Linx Security | $50,000,000 | (Apr 2, 2026)
TippingPoint Biosciences | $4,500,000 | (Apr 2, 2026)
Quantcore | $3,318,962 | (Apr 2, 2026)
Whirl AI | $8,900,000 | (Apr 2, 2026)
Semarion | $3,800,000 | (Apr 2, 2026)
Via Separations | $36,000,000 | (Apr 2, 2026)
Stedi | $50,000,000 | (Mar 31, 2026)